{"id":"https://openalex.org/W4367602182","doi":"https://doi.org/10.1158/1078-0432.c.6533209.v2","title":"Data from Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA","display_name":"Data from Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA","publication_year":2023,"publication_date":"2023-05-01","ids":{"openalex":"https://openalex.org/W4367602182","doi":"https://doi.org/10.1158/1078-0432.c.6533209.v2"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6533209.v2","doi":"https://doi.org/10.1158/1078-0432.c.6533209.v2","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6533209.v2","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6533209.v2","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060957245","display_name":"Peter Meade Anderson","orcid":"https://orcid.org/0000-0002-0011-0969","observed_orcids":["https://orcid.org/0000-0002-0011-0969"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Anderson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0011-0969","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065653743","display_name":"Maurizio L. Ghisoli","orcid":"https://orcid.org/0000-0001-7055-2618","observed_orcids":["https://orcid.org/0000-0001-7055-2618"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maurizio Ghisoli","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7055-2618","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009997118","display_name":"Brian D. Crompton","orcid":"https://orcid.org/0000-0001-9404-6621","observed_orcids":["https://orcid.org/0000-0001-9404-6621"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian D. Crompton","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9404-6621","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065388955","display_name":"Kelly S. Klega","orcid":"https://orcid.org/0000-0002-3424-2003","observed_orcids":["https://orcid.org/0000-0002-3424-2003"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kelly S. Klega","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3424-2003","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080725919","display_name":"Leonard H. Wexler","orcid":"https://orcid.org/0000-0003-0724-8263","observed_orcids":["https://orcid.org/0000-0003-0724-8263"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leonard H. Wexler","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0724-8263","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001610703","display_name":"Emily Kanaya Slotkin","orcid":"https://orcid.org/0000-0002-4463-5759","observed_orcids":["https://orcid.org/0000-0002-4463-5759"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emily K. Slotkin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4463-5759","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064537232","display_name":"Laura Stanbery","orcid":"https://orcid.org/0000-0001-7251-4076","observed_orcids":["https://orcid.org/0000-0001-7251-4076"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Stanbery","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7251-4076","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032051379","display_name":"Luisa Manning","orcid":"https://orcid.org/0000-0001-8568-1535","observed_orcids":["https://orcid.org/0000-0001-8568-1535"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luisa Manning","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8568-1535","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052040011","display_name":"Gladice Wallraven","orcid":"https://orcid.org/0000-0002-2145-3565","observed_orcids":["https://orcid.org/0000-0002-2145-3565"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gladice Wallraven","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2145-3565","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052049703","display_name":"Meghan Manley","orcid":"https://orcid.org/0000-0002-8600-8286","observed_orcids":["https://orcid.org/0000-0002-8600-8286"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meghan Manley","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8600-8286","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020525215","display_name":"Staci Horvath","orcid":"https://orcid.org/0000-0003-0181-8448","observed_orcids":["https://orcid.org/0000-0003-0181-8448"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Staci Horvath","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0181-8448","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006242906","display_name":"Ernest Bognar","orcid":"https://orcid.org/0000-0003-0314-7529","observed_orcids":["https://orcid.org/0000-0003-0314-7529"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ernest Bognar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0314-7529","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055054082","display_name":"John J. Nemunaitis","orcid":"https://orcid.org/0000-0002-2234-2381","observed_orcids":["https://orcid.org/0000-0002-2234-2381"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Nemunaitis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2234-2381","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vigil","display_name":"vigil","score":0.7559999823570251},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.8149999976158142},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":1.0},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9120000004768372},{"id":"https://openalex.org/keywords/ews-fli1-fusion","display_name":"EWS-FLI1 fusion","score":0.7850000262260437},{"id":"https://openalex.org/keywords/droplet-digital-pcr","display_name":"droplet digital PCR","score":0.7739999890327454},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.6779999732971191},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.8004462718963623},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7879074811935425},{"id":"https://openalex.org/C2778447413","wikidata":"https://www.wikidata.org/wiki/Q1238731","display_name":"Vigil","level":2,"score":0.7599425315856934},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.562127411365509},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.5336756110191345},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.47802814841270447},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.47200772166252136},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4459623694419861},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44072216749191284},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.4108913242816925},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.39302802085876465},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.3475974500179291},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.265113890171051},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.15531551837921143},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0859592854976654},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.0},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6533209.v2","doi":"https://doi.org/10.1158/1078-0432.c.6533209.v2","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6533209.v2","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6533209.v2","doi":"https://doi.org/10.1158/1078-0432.c.6533209.v2","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6533209.v2","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4320486355","https://openalex.org/W2600394651","https://openalex.org/W2890079555","https://openalex.org/W2342924512","https://openalex.org/W2587915541","https://openalex.org/W1505048261","https://openalex.org/W1975044418","https://openalex.org/W7148759548","https://openalex.org/W3031154866","https://openalex.org/W101175947"],"abstract_inverted_index":{"AbstractPurpose:":[0],"Treatment":[1],"options":[2],"for":[3,42,142,214],"recurrent":[4,57],"or":[5,58,212],"refractory":[6,59],"Ewing's":[7],"sarcoma":[8],"(ES)":[9],"are":[10],"limited.":[11],"Vigil":[12,41,87],"is":[13],"a":[14],"novel":[15],"autologous":[16],"tumor":[17,116],"cell":[18],"therapy":[19,65],"expressing":[20],"bi-shRNA":[21],"furin/GMCSF":[22],"plasmid,":[23],"which":[24],"previously":[25,161],"demonstrated":[26,241],"monotherapy":[27],"activity":[28],"in":[29,84,222,230,236],"advanced":[30],"ES.":[31],"Herein":[32],"we":[33],"report":[34],"safety":[35,143,242],"and":[36,48,74,109,129,144,178],"evidence":[37],"of":[38,136,158,243],"benefit":[39],"to":[40,82,234],"ES":[43,60],"as":[44],"potential":[45],"treatment.":[46],"Patients":[47],"Methods:":[49],"In":[50],"this":[51],"pilot":[52],"trial,":[53],"eligible":[54],"patients":[55,139,160,186,208,226],"with":[56,68,86],"who":[61],"failed":[62],"initial":[63],"standard-of-care":[64],"received":[66,162],"treatment":[67],"temozolomide":[69],"(TEM)":[70],"100":[71],"mg/m2/day":[72,78],"oral":[73],"irinotecan":[75],"(IRI)":[76],"50":[77],"oral,":[79],"Days":[80],"1":[81],"5,":[83],"combination":[85,244],"(1":[88],"\u00d7":[89],"106\u2013107":[90],"cells/mL/day":[91],"intradermal,":[92],"Day":[93],"15),":[94],"every":[95],"21":[96],"days":[97],"(Vigil/TEM/IRI).":[98],"Objective":[99],"response":[100,185,193],"rate":[101],"(ORR)":[102],"by":[103,122,187],"RECIST":[104],"v1.1,":[105],"progression-free":[106],"survival":[107,111],"(PFS),":[108],"overall":[110],"(OS)":[112],"were":[113,140,168],"assessed.":[114],"Circulating":[115],"(ct)":[117],"DNA":[118],"analysis":[119],"was":[120,200,220],"done":[121],"patient-specific":[123],"droplet":[124],"digital":[125],"PCR":[126],"on":[127],"baseline":[128],"serially":[130],"collected":[131],"on-treatment":[132],"samples.":[133],"Results:":[134],"Eight":[135],"10":[137],"enrolled":[138],"evaluable":[141,225],"efficacy":[145],"(mean":[146],"age":[147],"24.6;":[148],"12.6\u201346.1":[149],"years":[150],"old);":[151],"2":[152],"did":[153],"not":[154],"receive":[155],"Vigil.":[156],"Seven":[157],"8":[159,224],"TEM/IRI.":[163],"No":[164],"Vigil-related":[165],"adverse":[166],"events":[167],"reported.":[169],"Common":[170],"\u2265Grade":[171],"3":[172],"chemotherapy-related":[173],"toxicity":[174],"included":[175],"neutropenia":[176],"(50%)":[177],"thrombocytopenia":[179],"(38%).":[180],"We":[181],"observed":[182],"two":[183],"partial":[184],"RECIST;":[188],"both":[189],"showed":[190,209],"histologic":[191],"complete":[192],"without":[194],"additional":[195],"cancer":[196],"therapy.":[197],"Median":[198],"PFS":[199],"8.2":[201],"months":[202],"(95%":[203],"confidence":[204],"interval,":[205],"4.3\u2013NA).":[206],"Five":[207],"stable":[210],"disease":[211,237],"better":[213],"\u22656":[215],"months.":[216],"Patient-specific":[217],"EWS/FLI1":[218],"ctDNA":[219,231],"detectable":[221],"all":[223],"at":[227],"baseline.":[228],"Changes":[229],"levels":[232],"corresponded":[233],"changes":[235],"burden.":[238],"Conclusions:":[239],"Results":[240],"Vigil/TEM/IRI.":[245]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-05-02T00:00:00"}